Antioxidant Berberine-Derivative Inhibits Multifaceted Amyloid Toxicity
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Multiple lines of evidence indicate that amyloid beta (Aβ) peptide is responsible for the pathological devastation caused in Alzheimer's disease (AD). Aβ aggregation species predominantly contribute to multifaceted toxicity observed in neuronal cells including generation of reactive oxygen species (ROS), mitochondrial dysfunction, interfering with synaptic signaling, and activation of premature apoptosis. Herein, we report a natural product berberine-derived (Ber-D) multifunctional inhibitor to ameliorate in cellulo multifaceted toxicity of AD. The structural attributes of polyphenolic Ber-D have contributed to its efficient Cu chelation and arresting the redox cycle to prevent the generation of ROS and rescue biomacromolecules from oxidative damage. Ber-D inhibits metal-dependent and -independent Aβ aggregation, which is supported by in silico studies. Ber-D treatment averts mitochondrial dysfunction and corresponding neuronal toxicity contributing to premature apoptosis. These key multifunctional attributes make Ber-D a potential therapeutic candidate to ameliorate multifaceted Aβ toxicity in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“The oligomeric forms of Ab are considered to be highly lethal as they purge holes into the neuronal cell membrane and interact with synaptic cleft causing influx of excessive calcium into the cell disrupting the signaling pathways (Haass and Selkoe, 2007; Lee et al., 2017).”
BackgroundProtein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
Chiti, F., & Dobson, C. M. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045115 · Cited by 2,629 · cited 1×
“The multifactorial nature of the disease attributed to multifaceted toxicity has desisted researchers from developing effective medication for AD (Barnham and Bush, 2014; Huang and Mucke, 2012; Chiti and Dobson, 2017; Rajasekhar and Govindaraju 2018).”
BackgroundThe amyloid state and its association with protein misfolding diseases.
Knowles, T. P. J., Vendruscolo, M., & Dobson, C. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3810 · Cited by 2,382 · cited 1×
“Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder and accounts for more than 70% of all dementia (Knowles et al., 2014; Selkoe and Hardy, 2016).”
BackgroundTau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251 · cited 1×
“In addition to Ab, tau has been shown to play a key role in AD progression and pathology (Wang and Mandelkow, 2016).”
BackgroundAlzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758
Apoptosis in neurodegenerative disorders
Mattson, M. P. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35040009 · Cited by 1,605 · cited 1×
“The mitochondrial damage leads to activation of apoptosis, a process of programmed cell death, in response to irreversible cell damage (Mattson, 2000; Taylor et al., 2008).”
BackgroundAntioxidant assays for plant and food components
Moon, J.-K., & Shibamoto, T. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf803537k · Cited by 958 · cited 1×
“Berberine and Ber-D were found to interact with the core and surface sites of the Ab (17–42) protofibril 6 iScience 23, 101005, April 24, 2020 (Figure 3B) (Murugan et al., 2016).”
BackgroundA systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
Wang, J., Gu, B. J., Masters, C. L., & Wang, Y.-J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.111 · Cited by 808
The redox chemistry of the Alzheimer's disease amyloid β peptide
Smith, D. G., Cappai, R., & Barnham, K. J. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.002 · Cited by 608 · cited 2×
“As discussed vide supra, the Ab+Cu complex transforms into depot for ROS production through Fentontype reaction and a major contributor to the oxidative stress and biomolecular damage (Smith et al., 2007).”
BackgroundLee, S. J. C., Nam, E., Lee, H. J., Savelieff, M. G., & Lim, M. H. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00731g · Cited by 576 · cited 1×
“The oligomeric forms of Ab are considered to be highly lethal as they purge holes into the neuronal cell membrane and interact with synaptic cleft causing influx of excessive calcium into the cell disrupting the signaling pathways (Haass and Selkoe, 2007; Lee et al., 2017).”
BackgroundBiological metals and metal-targeting compounds in major neurodegenerative diseases
Barnham, K. J., & Bush, A. I. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00138a · Cited by 497 · cited 1×
“Moreover, it has been shown that elevated levels of cytochrome c (Cyt C) and caspases are expressed in Ab42-treated cells (Bobba et al., 2010).”
BackgroundMesquita, C. S., Oliveira, R., Bento, F., Geraldo, D., Rodrigues, J. V., & Marcos, J. C. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.04.034 · Cited by 480
The chemistry of Alzheimer’s disease
Rauk, A. (2009) · Chemical Society Reviews · doi:10.1039/b807980n · Cited by 417 · cited 2×
“amyloid beta (Ab) peptides with 37–43 amino acids generated by the proteolytic cleavage of a transmembrane human amyloid precursor protein (hAPP) are considered as the major culprits in causing multifaceted toxicity (Rauk, 2009; Nasica-Labouze et al., 2015; Wang et al., 2017).”
BackgroundToxicological Effects of Berberine and Sanguinarine
Singh, N., & Sharma, B. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00021 · Cited by 227
Robert, A., Liu, Y., Nguyen, M., & Meunier, B. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00119 · Cited by 212
Rajasekhar, K., & Govindaraju, T. (2018) · RSC Advances · doi:10.1039/c8ra03620a · Cited by 150
Self-citationHybrid Multifunctional Modulators Inhibit Multifaceted Aβ Toxicity and Prevent Mitochondrial Damage
Rajasekhar, K., Mehta, K., & Govindaraju, T. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00033 · Cited by 69 · cited 1×
“…have been extensively evaluated as aggregation modulators to prevent neurodegeneration, albeit with little or no success (Bulawa et al., 2012; Dwivedi and Iyer, 2014; Rajasekhar et al., 2015a, 2016, 2018, 2015b; Kaffy et al., 2016; Doig et al., 2017; Kumar et al., 2017; Samanta et al., 2019).”
BackgroundSelf-citationCopper Abolishes the β-Sheet Secondary Structure of Preformed Amyloid Fibrils of Amyloid-β42
House, E., Mold, M., Collingwood, J., Baldwin, A., Goodwin, S., & Exley, C. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1235 · Cited by 45 · cited 1×
“The redox metal ion such as Cu plays a key role in the aggravation of Ab toxicity (House et al., 2009).”
Background
Cited by
Chen, L.-L., Fan, Y.-G., Zhao, L.-X., Zhang, Q., & Wang, Z.-Y. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106301 · Cited by 200
Moorthy, H., & Govindaraju, T. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01319 · Cited by 64
Self-citationWang, K., Wang, L., Chen, L., Peng, C., Luo, B., Mo, J., & Chen, W. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1895909 · Cited by 55
“Recent years, there are many natural product derived small molecules and polymer based multi-target therapeutic strategies (Rajasekhar et al., 2018, 2020; Samanta et al., 2019; Datta et al., 2020).”
BackgroundMechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease
Padhi, D., & Govindaraju, T. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00335 · Cited by 47
Self-citation
Metadata
- Authors
- Rajasekhar, K., Samanta, S., Bagoband, V., Murugan, N. A., & Govindaraju, T.
- Venue
- iScience
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 23
- Issue
- 4
- Pages
- 101005
- ISSN
- 2589-0042 (ISSN-L)
- OpenAlex
- W3013279041
- Cited by
- 99
- References
- 21
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.